685 related articles for article (PubMed ID: 34519816)
1. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
Abbasi J
JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
[No Abstract] [Full Text] [Related]
2. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
[No Abstract] [Full Text] [Related]
3. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
[No Abstract] [Full Text] [Related]
4. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
[No Abstract] [Full Text] [Related]
5. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
Abbasi J
JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
[No Abstract] [Full Text] [Related]
6. Can immune responses predict which vaccines work best?
Cohen J
Science; 2021 Jul; 373(6551):142-143. PubMed ID: 34244387
[No Abstract] [Full Text] [Related]
7. Audio Interview: How Well Are Covid-19 Vaccines Working?
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
[No Abstract] [Full Text] [Related]
8. Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
Edara VV; Hudson WH; Xie X; Ahmed R; Suthar MS
JAMA; 2021 May; 325(18):1896-1898. PubMed ID: 33739374
[TBL] [Abstract][Full Text] [Related]
9. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
[No Abstract] [Full Text] [Related]
11. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
Liu Y; Liu J; Xia H; Zhang X; Zou J; Fontes-Garfias CR; Weaver SC; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
N Engl J Med; 2021 Jul; 385(5):472-474. PubMed ID: 33979486
[No Abstract] [Full Text] [Related]
12. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
Rössler A; Riepler L; Bante D; von Laer D; Kimpel J
N Engl J Med; 2022 Feb; 386(7):698-700. PubMed ID: 35021005
[No Abstract] [Full Text] [Related]
13. The long road.
Cohen J
Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
[No Abstract] [Full Text] [Related]
14. Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
Abbasi J
JAMA; 2021 Aug; 326(6):473. PubMed ID: 34374737
[No Abstract] [Full Text] [Related]
15. Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.
Joob B; Wiwanitkit V
Clin Appl Thromb Hemost; 2021; 27():10760296211020833. PubMed ID: 34142570
[No Abstract] [Full Text] [Related]
16. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
[TBL] [Abstract][Full Text] [Related]
17. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
Falsey AR; Frenck RW; Walsh EE; Kitchin N; Absalon J; Gurtman A; Lockhart S; Bailey R; Swanson KA; Xu X; Koury K; Kalina W; Cooper D; Zou J; Xie X; Xia H; Türeci Ö; Lagkadinou E; Tompkins KR; Shi PY; Jansen KU; Şahin U; Dormitzer PR; Gruber WC
N Engl J Med; 2021 Oct; 385(17):1627-1629. PubMed ID: 34525276
[No Abstract] [Full Text] [Related]
19. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
[No Abstract] [Full Text] [Related]
20. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
